Serra Gürcan Email & Phone Number

France

Paris, Île-De-France, Fransa

Developing scientific positioning for the RNA delivery therapeutics marketEmpowering client success with scientific expertise in lipid nanoparticle (LNP) formulationProactively initiate and design pioneering service offerings, products, and solutions in close collaboration with platform directors, setting new industry standards and anticipating market needs for impactful client and partner success.

Paris, Île-De-France, France

Formerly known as Precision NanoSystems Inc.Nurtured deep, trust-filled connections with customers, standing by their side as a trusted guide throughout the drug development process.Providing troubleshooting expertise within the LNP formulation workflow process to guide customers toward success in their drug development initiatives.Collaborated effectively with multiple research groups, providing expert guidance on LNP formation or nanoparticle formation, lipid choice, and operational parameters, leading to significant advancements in physical-chemical and biological success, and contributing as a co-author to several published articlesAs a speaker, workshop leader, seminar participant, panelist, or part of my current role, I educated the nanomedicine community about creating LNP and its technology's role in developing innovative therapies, including vaccine formulation, protein replacement, gene editing, and non-viral T-cell engineering.Inspiring success of sales by directing customers to stay on the journey with us, breaking a path towards developing novel drug delivery systems, and carefully driving the technology and service sales.

Paris Area, France

Secured a prestigious fellowship from Turkey TUBITAK 2214/A (International Research Fellowship for Ph.D. Students), which provided the opportunity to lead the development of a safe and highly efficient combined gene therapy system, followed by comprehensive evaluations on cellular models in the Cell and Particle Engineering for Therapeutic Applications team at University Paris Saclay. This groundbreaking approach involved encapsulating lower-dose glucocorticoids within solid lipid nanoparticles and complexing with TNF-α targeted siRNA to enhance the anti-inflammatory activity.This experience paved the way for my current role, where I am actively engaging in working with mRNA-LNPs.

Paris, Île-De-France, France

The French National Centre for Scientific Research (French: Centre national de la recherche scientifique, CNRS) | février 2018 - février 2019 | 1 year | Chatenay MalabryLed a pioneering project focused on developing an innovative combined drug delivery system, integrating RNA delivery strategies, and conducting in-depth assessments of nanoparticle manufacturing techniques.Effectively guided the project to its full potential, leading to the acquisition of a prestigious fellowship to advance further in its developmentI was funded by Labex Lermit Therapeutic Innovation (Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique)

Izmir, Turkey

The project was realized by industry-academy cooperation that was funded by TUBITAK 1505Project: Characterizing Turkey’s first mineral water-based skincare formulations obtained by the collaborated industryMy role was developing physical-chemical assays for the obtained dermal formulations by the collaborated company with the experiments below and presentation of the workExperimental techniques: pH, conductivity, rheology, viscosity, freeze-thaw assays, DLS

Izmir, Turkey

The project was an industry-academy collaboration that was funded by Abdi Ibrahim PharmaceuticalsProject title: Development and characterization of dermatological formulationsAim: Finding stable semi-solid formulations and characterizing them in short and long-term stability conditionsExperiments: DLS, pH, rheology, viscometerMy role was to conduct the experiments and write SOP formsProducts are on the Turkish market under the name of HAMETOL group

Pavia Area, Italy

Project Title: Investigation of the drug delivery systems that contain polymeric micelles on tissue repair by skin delivery Aim: Improving the drug loading of silver-sulfadiazine in chitosan-based polymeric micelles for wound healing therapyFor this purpose, the effect of molecular weight of chitosan was explored on forming polymeric micellesExperimental methods: dialysis, HPLC, NMR, DLS, DSC, rheology, Franz cell diffusion assay, microbiological efficacyI was supported by Erasmus+ Mobility Program for MSc students

Phd Fellow, Cell And Particle Engineering For Therapeutic Applications

Doctor Of Philosophy - Phd, Pharmaceutical Technology

Master Of Science - Ms, Pharmaceutics And Drug Design

Erasmus Mobility Program For Master Students, Department Of Drug Sciences, Pharmaceutical Chemistry And Technology

Bachelor'S Degree, Chemistry